시장보고서
상품코드
1601996

세계의 약물전달 기기 시장(2024-2028년)

Global Drug Delivery Devices Market 2024-2028

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 167 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

약물전달 기기 시장(2024-2028년)

약물전달 기기 시장은 2023-2028년 851억 달러 규모로 확대될 것으로 예상되며, 예측 기간 동안 6.2%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 약물전달 기기 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 만성질환의 유병률 증가, 전략 개발의 증가, 약물전달 기기에 대한 규제 당국의 승인 증가 등이 시장을 주도하고 있습니다.

시장 범위
기준 연도 2024년
종료 연도 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
전년 대비(2024년) 5.8%
CAGR 6.2%
증분 금액 851억 달러

이 보고서는 향후 몇 년 동안 약물전달 기기 시장의 성장을 주도할 주요 요인 중 하나로 자가 주사기 채택 증가를 꼽았습니다. 또한, 첨단 약물전달(약물전달) 시스템의 채택 확대, COVID-19 신약 및 백신 개발이 시장 수요를 견인할 것으로 예상됩니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 Technavio에 의한 분석

  • 가격 민감도·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
  • 인풋의 중요성과 차별화 요인
  • 혼란 요인
  • 성장 촉진요인과 과제의 영향

제3장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 밸류체인 분석

제4장 시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망(2023-2028년)

제5장 시장 규모 실적

  • 약물전달 기기 세계 시장(2018-2022년)
  • 투여 경로별 분석(2018-2022년)
  • 지역별 분석(2018-2022년)
  • 국가별 분석(2018-2022년)

제6장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 상황

제7장 시장 세분화 : 투여 경로별

  • 시장 부문
  • 비교 : 투여 경로별
  • 경구 : 시장 규모와 예측(2023-2028년)
  • 주입 : 시장 규모와 예측(2023-2028년)
  • 경폐 : 시장 규모와 예측(2023-2028년)
  • 기타 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 투여 경로별

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 캐나다 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 영국 : 시장 규모와 예측(2023-2028년)
  • 일본 : 시장 규모와 예측(2023-2028년)
  • 스페인 : 시장 규모와 예측(2023-2028년)
  • 인도 : 시장 규모와 예측(2023-2028년)
  • 브라질 : 시장 규모와 예측(2023-2028년)
  • 사우디아라비아 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 지역별

제10장 촉진요인, 과제, 기회, 억제요인

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 기회·억제요인

제11장 경쟁 상황

  • 개요
  • 경쟁 상황
  • 혼란 상황
  • 업계 리스크

제12장 경쟁 분석

  • 기업 개요
  • 기업 순위 지수
  • 기업의 시장 포지셔닝
  • AbbVie Inc.
  • Antares Pharma Inc.
  • Becton Dickinson and Co.
  • Biocorp
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

제13장 부록

ksm 24.12.10

Drug Delivery Devices Market 2024-2028

The drug delivery devices market is forecasted to grow by USD 85.1 bn during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic conditions, increased strategic developments, and increase in regulatory approvals for drug delivery devices.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.8%
CAGR6.2%
Incremental Value$85.1 bn

Technavio's drug delivery devices market is segmented as below:

By Route Of Administration

    • Oral
    • Injectable
    • Pulmonary
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the rising adoption of self-injectable devices as one of the prime reasons driving the drug delivery devices market growth during the next few years. Also, growing adoption of advanced drug delivery systems and development of new drugs and vaccines for covid-19 will lead to sizable demand in the market.

The report on the drug delivery devices market covers the following areas:

    • Drug Delivery Devices Market sizing
    • Drug Delivery Devices Market forecast
    • Drug Delivery Devices Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug delivery devices market vendors that include 3M Co., AbbVie Inc., Antares Pharma Inc., AptarGroup Inc., Becton Dickinson and Co., Biocorp, Elcam Medical Group, F. Hoffmann La Roche Ltd., Insulet Corp., Johnson and Johnson Inc., Koch Industries Inc., Merck KGaA, Nemera Group, Novartis AG, Pfizer Inc., SHL Medical AG, Teva Pharmaceutical Industries Ltd., uniQure NV, and West Pharmaceutical Services Inc.. Also, the drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Drug Delivery Devices Market 2018 - 2022
    • Historic Market Size - Data Table on Global Drug Delivery Devices Market 2018 - 2022 ($ billion)
  • 5.2 Route of Administration segment analysis 2018 - 2022
    • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
  • 5.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 5.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

6 Five Forces Analysis

  • 6.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 6.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 6.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 6.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 6.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 6.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 6.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

7 Market Segmentation by Route of Administration

  • 7.1 Market segments
    • Chart on Route of Administration - Market share 2023-2028 (%)
    • Data Table on Route of Administration - Market share 2023-2028 (%)
  • 7.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 7.3 Oral - Market size and forecast 2023-2028
    • Chart on Oral - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oral - Year-over-year growth 2023-2028 (%)
    • Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • 7.4 Injectable - Market size and forecast 2023-2028
    • Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
    • Chart on Injectable - Year-over-year growth 2023-2028 (%)
    • Data Table on Injectable - Year-over-year growth 2023-2028 (%)
  • 7.5 Pulmonary - Market size and forecast 2023-2028
    • Chart on Pulmonary - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Pulmonary - Market size and forecast 2023-2028 ($ billion)
    • Chart on Pulmonary - Year-over-year growth 2023-2028 (%)
    • Data Table on Pulmonary - Year-over-year growth 2023-2028 (%)
  • 7.6 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.7 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ billion)
    • Data Table on Market opportunity by Route of Administration ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.13 Spain - Market size and forecast 2023-2028
    • Chart on Spain - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Spain - Market size and forecast 2023-2028 ($ billion)
    • Chart on Spain - Year-over-year growth 2023-2028 (%)
    • Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • 9.14 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ billion)
    • Data Table on India - Market size and forecast 2023-2028 ($ billion)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.15 Brazil - Market size and forecast 2023-2028
    • Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Chart on Brazil - Year-over-year growth 2023-2028 (%)
    • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • 9.16 Saudi Arabia - Market size and forecast 2023-2028
    • Chart on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Saudi Arabia - Year-over-year growth 2023-2028 (%)
    • Data Table on Saudi Arabia - Year-over-year growth 2023-2028 (%)
  • 9.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Company ranking index
    • Company ranking index
  • 12.3 Market positioning of companies
    • Matrix on companies position and classification
    • 3M Co.
    • 3M Co. - Overview
    • 3M Co. - Business segments
    • 3M Co. - Key news
    • 3M Co. - Key offerings
    • 3M Co. - Segment focus
    • SWOT
  • 12.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 12.6 Antares Pharma Inc.
    • Antares Pharma Inc. - Overview
    • Antares Pharma Inc. - Product / Service
    • Antares Pharma Inc. - Key offerings
    • SWOT
  • 12.7 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 12.8 Biocorp
    • Biocorp - Overview
    • Biocorp - Product / Service
    • Biocorp - Key offerings
    • SWOT
  • 12.9 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 12.10 Johnson and Johnson Inc.
    • Johnson and Johnson Inc. - Overview
    • Johnson and Johnson Inc. - Business segments
    • Johnson and Johnson Inc. - Key news
    • Johnson and Johnson Inc. - Key offerings
    • Johnson and Johnson Inc. - Segment focus
    • SWOT
  • 12.11 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 12.12 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 12.13 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제